Rite Aid (NYSE:RAD) investors had a rough day, with shares cratering 7% after the pharmacy lowered its full-year guidance and reported that it anticipated only $0.04 per share in earnings versus analyst estimates of $0.08 per share. The sell-off felt a little extreme given the stock's stunning turnaround over the past several years.

But then again, competitor Walgreen (NASDAQ:WBA) reported better news, indicating that perhaps Rite Aid isn't executing as well in this competitive pharmacy environment.

So, was Rite Aid's sell-off overdone? In the video below, from Thursday's Market Checkup, the Motley Fool's health care-focused investing show, health care analysts Michael Douglass and David Williamson give their take.

Will this stock be your next multi-bagger?
Give us five minutes and we'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks one stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

David Williamson has no position in any stocks mentioned. Michael Douglass has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.